Почетна › ХОБП › Тексас › Houston
Kliničke studije za ХОБП u gradu Houston, TX
18 studija za ХОБП traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Тражи се учесникФаза 3
- GSK Investigational Site, Humble · 17 ми удаљено
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Тражи се учесникФаза 2
- Baylor College of Medicine Medical Center, Houston
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 2
- Research Site, Houston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Тражи се учесникФаза 3
- Se Houston- Site Number : 8400120, Houston
- Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 2/3
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Тражи се учесник
- Houston Methodist/Primary Critical Care, Houston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Тражи се учесникФаза 3
- Trio Clinical Trials- Site Number : 8400106, Houston
- HDH Research, Inc.- Site Number : 8400104, Houston
- Baylor College of Medicine- Site Number : 8400076, Houston
- и још 2
STRIVE Post-Market Registry Study
Тражи се учесникОпсервациона студија
- University of Texas Health Science Center at Houston, Houston
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Тражи се учесникОпсервациона студија
- The Respire Institute, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Тражи се учесникФаза 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Тражи се учесникФаза 3
- GSK Investigational Site, Houston
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Тражи се учесникФаза 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Тражи се учесникФаза 2
- Baylor College of Medicine, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Тражи се учесникФаза 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · 17 ми удаљено
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Тражи се учесникФаза 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Тражи се учесникОпсервациона студија
- Horizon Clinical Research Group, Houston
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Тражи се учесник
- Respire Research Institute, Houston
Studije za ХОБП u drugim gradovima
- Philadelphia, PA26 студија
- Miami, FL20 студија
- Birmingham, AL17 студија
- Baltimore, MD16 студија
- Boston, MA15 студија
- Orlando, FL15 студија
- Chicago, IL15 студија
- Dallas, TX13 студија
- New York City, NY12 студија
- Pittsburgh, PA11 студија
- Winston-Salem, NC11 студија
- Hialeah, FL10 студија
Ostale studije u gradu Houston
- Немалоклетни карцином плућа143 студија
- Рак дојке126 студија
- Рак (све врсте)124 студија
- Колоректални карцином101 студија
- Метастатски карцином100 студија
- Рак јајника90 студија
- Akutna mijeloidna leukemija88 студија
- Рак плућа78 студија
- Рак простате73 студија
- Карцином ендометријума69 студија
- Меланом61 студија
- Рак панкреаса59 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.